{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T04:21:38Z","timestamp":1741839698262,"version":"3.38.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,10,10]],"date-time":"2011-10-10T00:00:00Z","timestamp":1318204800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1752-1947-5-513","type":"journal-article","created":{"date-parts":[[2011,10,11]],"date-time":"2011-10-11T06:28:17Z","timestamp":1318314497000},"source":"Crossref","is-referenced-by-count":1,"title":["Methadone adverse reaction presenting with large increase in plasma methadone binding: a case series"],"prefix":"10.1186","volume":"5","author":[{"given":"Wenjie J","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weidong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Kreutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A","family":"Flockhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,10,10]]},"reference":[{"key":"1872_CR1","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/j.1399-6576.2008.01597.x","volume":"52","author":"OM Fredheim","year":"2008","unstructured":"Fredheim OM, Moksnes K, Borchgrevink PC, Kaasa S, Dale O: Clinical pharmacology of methadone for pain. Acta Anaesthesiol Scand. 2008, 52: 879-889. 10.1111\/j.1399-6576.2008.01597.x.","journal-title":"Acta Anaesthesiol Scand"},{"key":"1872_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1526-4637.2006.00289.x","volume":"9","author":"DJ Weschules","year":"2008","unstructured":"Weschules DJ, Bain KT, Richeimer S: Actual and potential drug interactions associated with methadone. Pain Med. 2008, 9: 315-344. 10.1111\/j.1526-4637.2006.00289.x.","journal-title":"Pain Med"},{"key":"1872_CR3","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/ALN.0b013e3181642938","volume":"108","author":"RA Totah","year":"2008","unstructured":"Totah RA, Sheffels P, Roberts T, Whittington D, Thummel K, Kharasch ED: Role of CYP2B6 in stereoselective human methadone metabolism. Anesthesiology. 2008, 108: 363-374. 10.1097\/ALN.0b013e3181642938.","journal-title":"Anesthesiology"},{"key":"1872_CR4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/hup.630","volume":"19","author":"JM Corkery","year":"2004","unstructured":"Corkery JM, Schifano F, Ghodse AH, Oyefeso A: The effects of methadone and its role in fatalities. Hum Psychopharmacol. 2004, 19: 565-576. 10.1002\/hup.630.","journal-title":"Hum Psychopharmacol"},{"key":"1872_CR5","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1080\/02791072.2006.10400590","volume":"38","author":"M Latowsky","year":"2006","unstructured":"Latowsky M: Methadone death, dosage and torsade de pointes: risk-benefit policy implications. J Psychoactive Drugs. 2006, 38: 513-519. 10.1080\/02791072.2006.10400590.","journal-title":"J Psychoactive Drugs"},{"key":"1872_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11606-009-1225-0","volume":"25","author":"V Modesto-Lowe","year":"2010","unstructured":"Modesto-Lowe V, Brooks D, Petry N: Methadone deaths: risk factors in pain and addicted populations. J Gen Intern Med. 2010, 25: 305-309. 10.1007\/s11606-009-1225-0.","journal-title":"J Gen Intern Med"},{"key":"1872_CR7","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1124\/dmd.110.032474","volume":"38","author":"WJ Lu","year":"2010","unstructured":"Lu WJ, Bies R, Kamden LK, Desta Z, Flockhart DA: Methadone: a substrate and mechanism-based inhibitor of CYP19 (aromatase). Drug Metab Dispos. 2010, 38: 1308-1313. 10.1124\/dmd.110.032474.","journal-title":"Drug Metab Dispos"},{"key":"1872_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/0165-6147(91)90515-T","volume":"12","author":"AJ Atkinson Jr","year":"1991","unstructured":"Atkinson AJ, Ruo TI, Frederiksen MC: Physiological basis of multicompartmental models of drug distribution. Trends Pharmacol Sci. 1991, 12: 96-101.","journal-title":"Trends Pharmacol Sci"},{"key":"1872_CR9","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/clpt.1987.47","volume":"41","author":"CE Inturrisi","year":"1987","unstructured":"Inturrisi CE, Colburn WA, Kaiko RF, Houde RW, Foley KM: Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain. Clin Pharmacol Ther. 1987, 41: 392-401. 10.1038\/clpt.1987.47.","journal-title":"Clin Pharmacol Ther"},{"key":"1872_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5414\/CPP38035","volume":"38","author":"MJ Garrido","year":"2000","unstructured":"Garrido MJ, Aguirre C, Troconiz IF, Marot M, Valle M, Zamacona MK, Calvo R: Alpha 1-acid glycoprotein (AAG) and serum protein binding of methadone in heroin addicts with abstinence syndrome. Int J Clin Pharmacol Ther. 2000, 38: 35-40.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"1872_CR11","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/jps.2600660615","volume":"66","author":"J Judis","year":"1977","unstructured":"Judis J: Binding of codeine, morphine, and methadone to human serum proteins. J Pharm Sci. 1977, 66: 802-806. 10.1002\/jps.2600660615.","journal-title":"J Pharm Sci"},{"key":"1872_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/clpt.1981.34","volume":"29","author":"MK Romach","year":"1981","unstructured":"Romach MK, Piafsky KM, Abel JG, Khouw V, Sellers EM: Methadone binding to orosomucoid (alpha 1-acid glycoprotein): determinant of free fraction in plasma. Clin Pharmacol Ther. 1981, 29: 211-217. 10.1038\/clpt.1981.34.","journal-title":"Clin Pharmacol Ther"},{"key":"1872_CR13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0960-0760(97)00120-9","volume":"63","author":"E Bajetta","year":"1997","unstructured":"Bajetta E, Ferrari L, Celio L, Mariani L, Miceli R, Di Leo A, Zilembo N, Buzzoni R, Spagnoli I, Martinetti A, Bichisao E, Seregni E: The aromatase inhibitor letrozole in advanced breast cancer: effects on serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels. J Steroid Biochem Mol Biol. 1997, 63: 261-267. 10.1016\/S0960-0760(97)00120-9.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1872_CR14","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.beem.2009.06.005","volume":"23","author":"R Tahboub","year":"2009","unstructured":"Tahboub R, Arafah BM: Sex steroids and the thyroid. Best Pract Res Clin Endocrinol Metab. 2009, 23: 769-780. 10.1016\/j.beem.2009.06.005.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1872_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0031-6997(25)00015-8","volume":"40","author":"JM Kremer","year":"1988","unstructured":"Kremer JM, Wilting J, Janssen LH: Drug binding to human alpha-1-acid glycoprotein in health and disease. Pharmacol Rev. 1988, 40: 1-47.","journal-title":"Pharmacol Rev"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1752-1947-5-513\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-5-513.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-5-513","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-5-513.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T18:05:36Z","timestamp":1741802736000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/1752-1947-5-513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,10]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1872"],"URL":"https:\/\/doi.org\/10.1186\/1752-1947-5-513","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2011,10,10]]},"article-number":"513"}}